In February, more precisely on the 28th, World Rare Disease Day is celebrated. The event was created in 2008 by the European Organization for Rare Diseases (Eurordis) to raise awareness of governments, health professionals, and the population about the existence and...

ANS is the acronym for National Supplementary Health Agency, an autarchy created to implement regulation of the private health market in the country. Linked to the Ministry of Health, ANS was created by Law 9.961/2000, with the aim of “Promoting defense of the public interest in supplementary health care, regulating sectoral operators – including terms of their relations with generation and consumers – and contributing for the development of health actions in the country.”

The National Commission for the Incorporation of Technologies in the Unified Health System (CONITEC) is the body responsible for assisting the Ministry of Health in the process of inclusion, exclusion, or modification of health technologies in the SUS and also in the elaboration or revision of Clinical Protocols and Guidelines Therapeutics (PCDT).

Created in 2003, the Brazilian Medicines Market Regulation Chamber (CMED) is the inter-ministerial body responsible for the economic regulation of the medicines market in Brazil.

Created by law nº 9,782 of January 26, 1999, the National Health Surveillance Agency (ANVISA) is an autarchy under a special regime, which has its headquarters and jurisdiction in the Federal District and is present throughout the Brazilian territory.

In this issue, continuing the theme, we will delve a little deeper into the numbers referring to the market
of “non-retail” market.

Latin America grew twice as much as the global drug market in 2020. The market has the largest growth opportunity in the pharmaceutical industry in the world.